Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 990.33 +7.07 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $983.26 | 52 Week High | $88.16 | |||
| Open | $975.00 | 52 Week Low | $67.88 | |||
| Day High | $991.22 | P/E | 229.24 | |||
| Day Low | $966.09 | EPS | $4.32 | |||
| Volume | 2,627,108 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.05 +0.44 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.61 | 52 Week High | $37.39 | |||
| Open | $26.54 | 52 Week Low | $28.25 | |||
| Day High | $27.13 | P/E | 16.39 | |||
| Day Low | $26.23 | EPS | $1.65 | |||
| Volume | 53,162,645 | |||||
